Pharmaceuticals

GSK invests £400m in Cambridge R&D centre

GSK is committing £400 million to a new research and development centre in Cambridge, a move that will lead to the closure of its historic Stevenage facility. Most scientists are expected to transfer to the new Cambridge location as the company aims for significant cost savings and revenue growth.